Sanofi, GSK to seek approval for Covid-19 vaccine after positive trial results

Sanofi SA SNYand GlaxoSmithKline PLC GSK said Wednesday that their jointly-developed coronavirus vaccine has shown positive results in final-stage clinical trials and that they intend to seek regulatory approval for the shot.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.